Search Results - interferon

3 Results Sort By:
Interferon Activation Score Is a Biomarker for Immunotherapy in Malignant Glioma Patients (UCLA Case No. 2024-043)
UCLA researchers from the Department of Neurosurgery have characterized immune responses in malignant glioma patients receiving immunotherapy to develop a robust biomarker that will allow prediction of clinical outcomes following treatment. BACKGROUND: Malignant gliomas are the most common primary brain tumors in adults. No cures exist and most gliomas...
Published: 10/23/2024   |   Inventor(s): Robert Prins
Keywords(s): adjuvant therapy, Biomarker, Chemotherapy, Clinical Trial, dendritic cell vaccination, Glioblastoma, Glioma, immune response, Immunotherapy, interferon, malignant glioma
Category(s): Diagnostic Markers > Immunology, Diagnostic Markers > Cancer, Therapeutics > Inflammation And Inflammatory Diseases, Therapeutics > Oncology, Therapeutics > CNS and Neurology
Diagnostic Marker for Improving Treatment Outcomes of Hepatitis C
Abstract: The National Cancer Institute (NCI) Division of Cancer Epidemiology and Genetics (DCEG)  Immunoepidemiology Branch is seeking statements of capability or interest from parties interested in collaborative research to further co-develop a gene-based diagnostic for Hepatitis C virus (HepC, HCV). NCI Researchers have discovered Interferon-lambda...
Published: 4/8/2024   |   Inventor(s): Liudmila Prokunina-Olsson, Thomas O'Brien, Brian Muchmore, Raymond Donnelly, Patricia Porter-Gill
Keywords(s): HCV, hepatitis C virus, HepC, IFN L4, IL28B, INTERFERON, Interferon-lambda 4
Category(s): Collaboration Sought > Collaboration, TherapeuticArea > Infectious Disease, Collaboration Sought > Licensing, Application > Diagnostics
Therapeutic Methods Based on In Vivo Modulation of the Production of Interferon gamma
The technology offered for licensing is in the field of Therapeutics. More specifically, the technology relates to biological ligands and their use as modulators of the production of Interferon gamma as a means to treat a broad spectrum of diseases. The invention describes and claims antibodies and other ligands that can stimulate Natural Killer (NK)...
Published: 10/28/2024   |   Inventor(s): Sumati (Sumi) Rajagopalan, Eric Long
Keywords(s): Against, antibodies, DB3XXX, DB4XXX, DBXXXX, DC1XXX, DCXXXX, Directed, DXXXXX, Gamma, INTERFERON, KIR2DL4, LIGANDS, Patent Category - Biotechnology, production, RECEPTOR
Category(s): Collaboration Sought > Licensing, Application > Therapeutics, TherapeuticArea > Infectious Disease, Application > Vaccines